Comorbidities and mortality risk factors for patients with bronchiectasis-Reference-Cited by-同舟云学术

Comorbidities and mortality risk factors for patients with bronchiectasis

Published:2021-02-17 Issue:5 Volume:15 Page:623-634
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Clofent David¹²,Álvarez Antonio¹²,Traversi Letizia³,Culebras Mario¹²,Loor Karina¹²,Polverino Eva¹²

Affiliation:

1. Vall d’Hebron Institute of Research (VHIR) - Respiratory Disease Department, Hospital Universitari Vall d’Hebron (HUVH) Passeig Vall d’Hebron, 119–129, Barcelona, Spain

2. Respiratory Diseases, Vall d’Hebron University Hospital, Barcelona, Catalunya, Spain

3. Department of Medicine and Surgery, Respiratory Diseases, Università dell’Insubria, Varese, Italy

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2021.1886084

Reference133 articles.

1. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study

2. Prevalence and incidence of bronchiectasis in Catalonia, Spain: A population-based study

3. Bronchiectasis and Chronic Airway Disease

4. High Prevalence of Bronchiectasis in Adults: Analysis of CT Findings in a Health Screening Program

5. Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Comorbidities and Gender Differences in Survival in Patients With Bronchiectasis;Archivos de Bronconeumología;2024-06

2. The impact of smoking on bronchiectasis and its comorbidities;Expert Review of Respiratory Medicine;2024-05-03

3. Comparative effectiveness and safety of inhaled corticosteroid plus long-acting β ₂ -agonist fixed-dose combinations vs. long-acting muscarinic antagonist in bronchiectasis;Expert Review of Clinical Pharmacology;2024-01-26

4. The Role of High-Flow Nasal Cannula Oxygen Therapy in Exercise Testing and Pulmonary Rehabilitation: A Review of the Current Literature;Journal of Clinical Medicine;2023-12-30

5. Impact of Comorbidities in Clinical Outcomes in Patients Admitted for Exacerbation of Bronchiectasis;Archivos de Bronconeumología;2023-11